• Groupe canadien de recherche en soins intensifs
    Le Groupe canadien de recherche en soins intensifs (CCCTG) est un groupe collaboratif voué à la poursuite de l’excellence et à l’avancement de la recherche en soins intensifs au Canada.
  • Groupe canadien de recherche en soins intensifs
    Plus de 30 programmes de recherche sont en cours au CCCTG et plus de 100 articles évalués par les pairs ont été publiés, toujours avec répercussions directes sur la pratique clinique en soins intensifs.
  • Groupe canadien de recherche en soins intensifs
    Le Groupe canadien de recherche en soins intensifs (CCCTG) est un organisme national de plus 300 membres intéressés à la recherche sur la prise en charge des patients gravement malades.
  • Groupe canadien de recherche en soins intensifs
    Le soutien du CCCTG indique son engagement formel à s’assurer que la recherche sera entreprise avec rigueur et éthique et communiquée en temps opportun, de manière efficace.
Coordonnées

Institution

Sunnybrook Health Sciences Centre

City

Toronto

Contacter ce membre

Rob Fowler

Rob Fowler is an Associate Professor of Medicine at the University of Toronto, an internist and intensivist, and Director of Research for the Department of Critical Care Medicine and the Department of Medicine at Sunnybrook Health Sciences Centre.

Rob Fowler received his medical degree at McGill University, his residency training at the University of Toronto, and completed a critical care fellowship and Master of Science degree at Stanford University. He is a past Clinician-Scientist of the Ontario Ministry of Health and Long-term Care and a current Clinician-Scientist of the Heart and Stroke Foundation.

Rob’s academic interests include the access and outcomes of care for critically ill patients, with a particular interest on end-of-life care. He was the critical care lead for the American Thoracic Society statement on the Association between Health Insurance Status and Access, Care Delivery, and Outcomes for Patients Who Are Critically Ill; has investigated differential use of critical care resources according to gender and age; and, has highlighted how selective patient inclusion in clinical trials leads to deceased generalizability of all our research findings. During the 2003 SARS epidemic, he helped provide the first descriptions of critically ill patients and modes of disease transmission. More recently, working with colleagues throughout North America, Asia, Europe and Australia, Rob helped international research programs to study clinical characteristics, treatments and outcomes of patients with H1N1-related critical illness. Rob has previously examined costs of caring for the critically ill and is the lead investigator of a multi-country economic evaluation of venous thromboembolism prevention in the ICU.